{"columns":["Cancer code","Cancer description","Superfamily ID","FunFam number","FunFam Name","EF","p-val (BH corrected)"],"index":[0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,306,307,308,309,310,311,312,313,314,315,316,317,318,319,320,321,322,323,324,325,326,327,328,329,330,331,332,333,334,335,336,337,338,339,340,341,342,343,344,345,346,347,348,349,350,351,352,353,354,355,356,357,358,359,360,361,362,363,364,365,366,367,368,369,370,371,372,373,374,375,376,377,378,379,380,381,382,383,384,385,386,387,388,389,390,391,392,393,394,395,396,397,398,399,400,401,402,403,404],"data":[["BLCA","Bladder cancer","2.10.220.10",5834,"Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)",10.361,0.0],["BLCA","Bladder cancer","2.160.10.10",81454,"Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1)",5.944,0.0],["BLCA","Bladder cancer","3.30.420.40",78669,"Actin 7-like protein",3.451,0.00089],["BLCA","Bladder cancer","1.25.40.70",2223,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine\\/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)",3.282,0.0],["BLCA","Bladder cancer","2.60.40.60",18149,"Pcdha6 protein (Protocadherin alpha 6)",2.931,0.0],["BLCA","Bladder cancer","2.130.10.10",102894,"F-box\\/WD repeat-containing protein sel-10 (Egg laying defective protein 41) (Suppressor\\/enhancer of lin-12 protein 10)",2.526,0.0],["BLCA","Bladder cancer","1.10.10.10",264994,"Forkhead box protein G1 (Brain factor 1) (BF-1) (BF1) (Brain factor 2) (BF-2) (BF2) (hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1) (HFK1) (Forkhead-related protein FKHL2) (HFK2) (Forkhead-related protein FKHL3) (HFK3)",2.506,0.0],["BLCA","Bladder cancer","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.461,0.0],["BLCA","Bladder cancer","2.160.10.10",81861,"Zinc finger protein 585B (zinc finger protein 41-like protein)",2.175,0.02512],["BLCA","Bladder cancer","3.40.50.410",19758,"Protein transport protein Sec24D (cDNA FLJ43974 fis, clone TESTI4018101, highly similar to Protein transport protein Sec24D)",2.135,0.02201],["BLCA","Bladder cancer","2.60.40.10",136041,"Opioid binding protein\\/cell adhesion molecule-like isoform c (Opioid-binding protein\\/cell adhesion molecule) (cDNA, FLJ79390, highly similar to Opioid-binding protein\\/cell adhesion molecule)",2.133,0.02891],["BLCA","Bladder cancer","1.10.10.10",264742,"Interferon regulatory factor 5 (Interferon regulatory factor 5 variant 11)",2.116,0.02367],["BLCA","Bladder cancer","2.60.40.60",18207,"Protocadherin beta-12 (cDNA FLJ55315, highly similar to Protocadherin beta 12) (cDNA, FLJ79059, highly similar to Protocadherin beta 12)",1.984,0.01026],["BLCA","Bladder cancer","3.40.50.1820",115381,"Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)]",1.684,0.0355],["BLCA","Bladder cancer","1.10.565.10",5028,"Retinoic acid receptor RXR-gamma-A (Nuclear receptor subfamily 2 group B member 3-A) (Retinoic acid receptor RXR-alpha) (Retinoid X receptor alpha) (Retinoid X receptor gamma-A)",1.406,0.03968],["BLCA","Bladder cancer","1.20.1080.10",5095,"Glycerol uptake facilitator protein (MIP family channel protein)",1.208,0.02367],["BLCA","Bladder cancer","3.40.50.300",630744,"Ras protein let-60 (Abnormal cell lineage protein 34) (Lethal protein 60)",1.112,0.03683],["BRCA","Breast invasive carcinoma","3.30.200.20",2866,"Receptor tyrosine-protein kinase erbB-2 (cDNA FLJ59426, highly similar to Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1))",9.414,0.0],["BRCA","Breast invasive carcinoma","2.40.155.10",20824,"Zinc finger protein 443 (Krueppel-type zinc finger protein ZK1)",6.855,0.0],["BRCA","Breast invasive carcinoma","2.30.29.30",22238,"RAC-alpha serine\\/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene)",3.399,0.0],["BRCA","Breast invasive carcinoma","1.10.1070.11",1687,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine\\/threonine protein kinase PIK3CA) (EC 2.7.11.1)",2.844,0.0],["BRCA","Breast invasive carcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.76,0.0],["BRCA","Breast invasive carcinoma","2.60.40.60",18709,"Fizzy-related protein homolog",2.54,0.00126],["BRCA","Breast invasive carcinoma","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",2.518,0.0],["BRCA","Breast invasive carcinoma","1.25.40.70",2223,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine\\/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)",2.255,0.0],["BRCA","Breast invasive carcinoma","1.25.10.10",68666,"Splicing factor 3B subunit 1 (146 kDa nuclear protein) (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)",2.175,0.00126],["BRCA","Breast invasive carcinoma","1.10.10.10",264994,"Forkhead box protein G1 (Brain factor 1) (BF-1) (BF1) (Brain factor 2) (BF-2) (BF2) (hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1) (HFK1) (Forkhead-related protein FKHL2) (HFK2) (Forkhead-related protein FKHL3) (HFK3)",2.165,0.0],["BRCA","Breast invasive carcinoma","2.60.40.60",18229,"Protocadherin alpha 13 (RCG49388, isoform CRA_c)",2.136,0.00126],["BRCA","Breast invasive carcinoma","2.60.40.60",18207,"Protocadherin beta-12 (cDNA FLJ55315, highly similar to Protocadherin beta 12) (cDNA, FLJ79059, highly similar to Protocadherin beta 12)",1.793,0.03591],["BRCA","Breast invasive carcinoma","2.60.40.10",136415,"Btn1a1 protein (Butyrophilin subfamily 1 member A1) (Butyrophilin, subfamily 1, member A1, isoform CRA_d)",1.722,0.04277],["COAD","Colon adenocarcinoma","3.30.200.20",64824,"Epidermal growth factor receptor (Epidermal growth factor receptor isoform 1)",6.747,0.0],["COAD","Colon adenocarcinoma","3.30.160.60",23366,"Early growth response protein 1 (EGR-1) (Nerve growth factor-induced protein A) (NGFI-A) (Transcription factor Zif268) (Zinc finger protein Krox-24)",5.643,0.0],["COAD","Colon adenocarcinoma","3.30.1520.10",1289,"Sorting nexin 13, isoform CRA_e (cDNA FLJ13678 fis, clone PLACE1012031, highly similar to Sorting nexin-13)",5.124,0.0],["COAD","Colon adenocarcinoma","3.30.40.10",59876,"E3 ubiquitin-protein ligase CBL-B (EC 6.3.2.-) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)",4.853,0.0],["COAD","Colon adenocarcinoma","2.20.100.10",10057,"Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B) (p53-regulated receptor for death and life protein 1)",4.445,0.0],["COAD","Colon adenocarcinoma","2.160.10.10",33722,"CDNA, FLJ94233, highly similar to Homo sapiens zinc finger protein 189 (ZNF189), mRNA",3.346,0.00218],["COAD","Colon adenocarcinoma","1.20.120.330",23932,"Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)",3.038,0.0],["COAD","Colon adenocarcinoma","1.10.30.10",4308,"Sry-box containing protein 9a (Transcription factor SOX9)",2.985,0.00218],["COAD","Colon adenocarcinoma","1.10.30.10",4396,"Sex-determining region Y protein (Testis-determining factor)",2.876,0.0],["COAD","Colon adenocarcinoma","4.10.1140.10",38,"Epidermal growth factor receptor (Epidermal growth factor receptor isoform 1)",2.775,0.02719],["COAD","Colon adenocarcinoma","2.60.40.10",135788,"Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)",2.768,0.01992],["COAD","Colon adenocarcinoma","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",2.74,0.0],["COAD","Colon adenocarcinoma","1.10.10.10",264742,"Interferon regulatory factor 5 (Interferon regulatory factor 5 variant 11)",2.586,0.0],["COAD","Colon adenocarcinoma","3.30.505.10",1631,"Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase SYP) (SH-PTP2) (SHP-2) (Shp2)",2.508,0.02945],["COAD","Colon adenocarcinoma","1.10.510.10",79140,"Serine\\/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5\\/p35-regulated kinase) (CPRK) (Kinase\\/phosphatase\\/inhibitor 2) (Lemur tyrosine kinase 2) (Serine\\/threonine-protein kinase KPI-2)",2.409,0.01902],["COAD","Colon adenocarcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.405,0.0],["COAD","Colon adenocarcinoma","3.30.505.10",4290,"MGC68892 protein",2.265,0.02905],["COAD","Colon adenocarcinoma","3.30.70.330",42834,"GH26440p (RNA-binding protein) (RNA-binding protein 9, isoform E) (RNA-binding protein 9, isoform F) (RNA-binding protein 9, isoform G) (RNA-binding protein 9, isoform H)",2.15,0.04024],["COAD","Colon adenocarcinoma","3.40.50.10330",6271,"RE64552p (Sphingosine kinase 1, isoform A) (EC 2.7.1.107) (Sphingosine kinase 1, isoform B) (EC 2.7.1.107)",2.149,0.0083],["COAD","Colon adenocarcinoma","2.130.10.10",102894,"F-box\\/WD repeat-containing protein sel-10 (Egg laying defective protein 41) (Suppressor\\/enhancer of lin-12 protein 10)",2.129,0.0],["COAD","Colon adenocarcinoma","1.10.510.10",78531,"Raf homolog serine\\/threonine-protein kinase (EC 2.7.11.1) (Abnormal cell lineage protein 45)",2.071,0.0],["COAD","Colon adenocarcinoma","3.40.50.300",627822,"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1) (dEF-G1) (Protein iconoclast)",1.982,0.04265],["COAD","Colon adenocarcinoma","1.10.1070.11",1687,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine\\/threonine protein kinase PIK3CA) (EC 2.7.11.1)",1.873,0.0],["COAD","Colon adenocarcinoma","2.60.200.10",492,"Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4 homolog) (SMAD family member 4) (SMAD 4) (Smad4)",1.838,0.0],["COAD","Colon adenocarcinoma","2.60.350.10",9528,"Cadherin-2 (CDw325) (Neural cadherin) (N-cadherin) (CD antigen CD325)",1.825,0.02668],["COAD","Colon adenocarcinoma","1.10.510.10",78966,"Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF\\/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)",1.772,0.01083],["COAD","Colon adenocarcinoma","2.60.40.60",18207,"Protocadherin beta-12 (cDNA FLJ55315, highly similar to Protocadherin beta 12) (cDNA, FLJ79059, highly similar to Protocadherin beta 12)",1.608,0.00943],["COAD","Colon adenocarcinoma","2.60.40.60",18229,"Protocadherin alpha 13 (RCG49388, isoform CRA_c)",1.579,0.02554],["COAD","Colon adenocarcinoma","1.10.10.10",264994,"Forkhead box protein G1 (Brain factor 1) (BF-1) (BF1) (Brain factor 2) (BF-2) (BF2) (hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1) (HFK1) (Forkhead-related protein FKHL2) (HFK2) (Forkhead-related protein FKHL3) (HFK3)",1.559,0.0415],["COAD","Colon adenocarcinoma","1.20.1070.10",45670,"Relaxin receptor 2 (G-protein coupled receptor 106) (G-protein coupled receptor affecting testicular descent) (Leucine-rich repeat-containing G-protein coupled receptor 8) (Relaxin family peptide receptor 2)",1.547,0.0],["COAD","Colon adenocarcinoma","1.25.40.70",2223,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine\\/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)",1.528,0.00943],["COAD","Colon adenocarcinoma","2.60.350.10",9563,"Protocadherin gamma B4 (Protocadherin gamma subfamily B, 4)",1.51,0.02613],["COAD","Colon adenocarcinoma","1.10.510.10",79298,"Bone morphogenetic protein receptor 1B (Bone morphogenetic protein receptor type IB) (Bone morphogenetic protein type 1 receptor) (Bone morphogenetic protein type IB receptor)",1.503,0.0],["COAD","Colon adenocarcinoma","3.90.190.10",11605,"Dual specificity protein phosphatase 4 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2) (MAP kinase phosphatase 2) (MKP-2)",1.468,0.04028],["COAD","Colon adenocarcinoma","1.50.10.10",18715,"Edem1, isoform A (EC 3.2.1.113) (Edem1, isoform B) (EC 3.2.1.113) (Edem1, isoform C) (EC 3.2.1.113) (Edem1, isoform D) (EC 3.2.1.113) (GH14693p) (LD21416p)",1.291,0.03502],["COAD","Colon adenocarcinoma","3.40.50.300",630744,"Ras protein let-60 (Abnormal cell lineage protein 34) (Lethal protein 60)",1.126,0.0],["DLBC","Lymphoid Neoplasm Diffuse Large B-cell Lymphoma","2.160.10.10",18313,"CDNA FLJ60220, highly similar to B-cell lymphoma 6 protein",4.234,0.0],["DLBC","Lymphoid Neoplasm Diffuse Large B-cell Lymphoma","2.170.270.10",5098,"Histone-lysine N-methyltransferase CLF (EC 2.1.1.43) (Polycomb group protein CURLY LEAF) (Protein INCURVATA 1) (Protein SET DOMAIN GROUP 1) (Protein photoperiod insensitive flowering)",3.348,0.0],["DLBC","Lymphoid Neoplasm Diffuse Large B-cell Lymphoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.764,0.0],["DLBC","Lymphoid Neoplasm Diffuse Large B-cell Lymphoma","3.40.50.10140",4333,"Myeloid differentiation primary response gene (88), isoform CRA_b (Myeloid differentiation primary response protein MyD88)",2.209,0.0],["ESCA","Esophageal carcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.74,0.0],["ESCA","Esophageal carcinoma","1.25.40.70",2223,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine\\/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)",2.68,0.022],["ESCA","Esophageal carcinoma","2.60.200.10",492,"Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4 homolog) (SMAD family member 4) (SMAD 4) (Smad4)",2.349,0.0],["ESCA","Esophageal carcinoma","2.60.40.60",18229,"Protocadherin alpha 13 (RCG49388, isoform CRA_c)",2.263,0.0396],["GBM","Glioblastoma multiforme","2.10.220.10",11299,"Epidermal growth factor receptor (Epidermal growth factor receptor isoform 3) (Epidermal growth factor receptor, isoform CRA_a)",8.29,0.0],["GBM","Glioblastoma multiforme","2.160.10.10",22734,"Zinc finger protein 646",7.34,0.0],["GBM","Glioblastoma multiforme","3.30.420.40",68894,"Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)",5.997,0.0],["GBM","Glioblastoma multiforme","3.90.640.10",8095,"Heat shock 70 kDa protein 3 (Heat shock cognate 70 kDa protein 3) (Heat shock cognate protein 70-3) (AtHsc70-3) (Heat shock protein 70-3) (AtHsp70-3)",5.502,0.0],["GBM","Glioblastoma multiforme","2.10.220.10",11249,"Epidermal growth factor receptor (Epidermal growth factor receptor isoform 3) (Epidermal growth factor receptor, isoform CRA_a)",5.157,0.0],["GBM","Glioblastoma multiforme","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",3.863,0.0],["GBM","Glioblastoma multiforme","2.10.220.10",9723,"Epidermal growth factor receptor (Epidermal growth factor receptor isoform 3) (Epidermal growth factor receptor, isoform CRA_a)",3.835,0.00096],["GBM","Glioblastoma multiforme","1.10.510.10",79478,"Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (EC 2.7.11.10) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA)",2.845,0.0],["GBM","Glioblastoma multiforme","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.75,0.0],["GBM","Glioblastoma multiforme","3.30.450.20",87869,"Hypoxia-inducible factor 1, alpha subunit (Basic helix-loop-helix transcription factor), isoform CRA_b (Hypoxia-inducible factor 1, alpha subunit, variant K12NR)",2.749,0.0],["GBM","Glioblastoma multiforme","2.120.10.80",463,"Leucine-zipper-like transcriptional regulator 1 (LZTR-1)",2.464,0.0],["GBM","Glioblastoma multiforme","1.20.1050.10",15622,"Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST 1-1) (GST class-mu 1) (Glutathione S-transferase GT8.7) (pmGT10)",2.346,0.0],["GBM","Glioblastoma multiforme","3.30.505.10",4305,"Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)",2.222,0.00872],["GBM","Glioblastoma multiforme","2.160.10.10",50471,"Zinc finger protein 429",2.204,0.0],["GBM","Glioblastoma multiforme","2.160.10.10",42759,"Zinc finger protein 429",2.079,0.0],["GBM","Glioblastoma multiforme","3.10.50.40",13891,"Peptidyl-prolyl cis-trans isomerase FKBP10 (PPIase FKBP10) (EC 5.2.1.8) (65 kDa FK506-binding protein) (65 kDa FKBP) (FKBP-65) (FK506-binding protein 10) (FKBP-10) (Immunophilin FKBP65) (Rotamase)",1.728,0.0054],["GBM","Glioblastoma multiforme","3.10.50.40",13877,"Peptidyl-prolyl cis-trans isomerase FKBP10 (PPIase FKBP10) (EC 5.2.1.8) (65 kDa FK506-binding protein) (65 kDa FKBP) (FKBP-65) (FK506-binding protein 10) (FKBP-10) (Immunophilin FKBP65) (Rotamase)",1.402,0.0285],["GBM","Glioblastoma multiforme","1.10.510.10",79008,"Calcium\\/calmodulin-dependent protein kinase type II delta 2 chain (EC 2.7.11.17) (Calcium\\/calmodulin-dependent protein kinase type II delta-A chain) (CaM kinase II subunit delta-A) (CaM-kinase II delta-A chain) (CaMK-II subunit delta-A)",1.269,0.02224],["GLI","Gliomas","2.170.300.10",7708,"Neurogenic locus notch homolog protein 1 (Notch gene homolog 1 (Drosophila))",10.456,0.0],["GLI","Gliomas","1.10.30.10",4421,"HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2)",8.837,0.0],["GLI","Gliomas","2.10.220.10",11299,"Epidermal growth factor receptor (Epidermal growth factor receptor isoform 3) (Epidermal growth factor receptor, isoform CRA_a)",7.78,0.0],["GLI","Gliomas","2.160.10.10",22734,"Zinc finger protein 646",6.816,0.0],["GLI","Gliomas","2.10.220.10",11249,"Epidermal growth factor receptor (Epidermal growth factor receptor isoform 3) (Epidermal growth factor receptor, isoform CRA_a)",5.69,0.0],["GLI","Gliomas","3.30.420.40",68894,"Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8)",5.578,0.0],["GLI","Gliomas","3.90.640.10",8095,"Heat shock 70 kDa protein 3 (Heat shock cognate 70 kDa protein 3) (Heat shock cognate protein 70-3) (AtHsc70-3) (Heat shock protein 70-3) (AtHsp70-3)",5.033,0.0],["GLI","Gliomas","2.10.220.10",9723,"Epidermal growth factor receptor (Epidermal growth factor receptor isoform 3) (Epidermal growth factor receptor, isoform CRA_a)",4.231,0.0],["GLI","Gliomas","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",3.788,0.0],["GLI","Gliomas","1.10.510.10",78531,"Raf homolog serine\\/threonine-protein kinase (EC 2.7.11.1) (Abnormal cell lineage protein 45)",3.306,0.0],["GLI","Gliomas","3.40.50.300",632587,"DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)",3.088,0.00227],["GLI","Gliomas","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.789,0.0],["GLI","Gliomas","1.10.287.70",16546,"Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Smooth muscle calcium channel blocker receptor) (CACB-receptor) (Voltage-gated calcium channel subunit alpha Cav1.2)",2.622,0.00514],["GLI","Gliomas","1.10.510.10",79478,"Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (EC 2.7.11.10) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA)",2.567,0.0],["GLI","Gliomas","3.30.450.20",87869,"Hypoxia-inducible factor 1, alpha subunit (Basic helix-loop-helix transcription factor), isoform CRA_b (Hypoxia-inducible factor 1, alpha subunit, variant K12NR)",2.535,0.0],["GLI","Gliomas","1.20.1050.10",15622,"Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST 1-1) (GST class-mu 1) (Glutathione S-transferase GT8.7) (pmGT10)",2.346,0.0],["GLI","Gliomas","2.120.10.80",463,"Leucine-zipper-like transcriptional regulator 1 (LZTR-1)",2.19,0.00324],["GLI","Gliomas","2.160.10.10",50471,"Zinc finger protein 429",2.18,0.0],["GLI","Gliomas","2.160.10.10",42759,"Zinc finger protein 429",2.099,0.0],["GLI","Gliomas","1.20.5.170",18070,"Keratin, type I cytoskeletal 25 (Cytokeratin-25) (CK-25) (Keratin-25) (K25) (Type I inner root sheath-specific keratin-K25irs1) (Type I keratin intermediate filament IRSa1)",2.012,0.03822],["GLI","Gliomas","2.60.40.60",18201,"Pcdha6 protein (Protocadherin alpha 6)",1.981,0.04053],["GLI","Gliomas","3.30.505.10",4305,"Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)",1.909,0.01972],["GLI","Gliomas","3.10.50.40",13891,"Peptidyl-prolyl cis-trans isomerase FKBP10 (PPIase FKBP10) (EC 5.2.1.8) (65 kDa FK506-binding protein) (65 kDa FKBP) (FKBP-65) (FK506-binding protein 10) (FKBP-10) (Immunophilin FKBP65) (Rotamase)",1.707,0.01113],["GLI","Gliomas","1.25.40.70",2223,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine\\/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)",1.609,0.03744],["GLI","Gliomas","3.10.50.40",13877,"Peptidyl-prolyl cis-trans isomerase FKBP10 (PPIase FKBP10) (EC 5.2.1.8) (65 kDa FK506-binding protein) (65 kDa FKBP) (FKBP-65) (FK506-binding protein 10) (FKBP-10) (Immunophilin FKBP65) (Rotamase)",1.418,0.0219],["GLI","Gliomas","1.10.510.10",79008,"Calcium\\/calmodulin-dependent protein kinase type II delta 2 chain (EC 2.7.11.17) (Calcium\\/calmodulin-dependent protein kinase type II delta-A chain) (CaM kinase II subunit delta-A) (CaM-kinase II delta-A chain) (CaMK-II subunit delta-A)",1.379,0.0016],["GLI","Gliomas","3.40.718.10",9686,"Isocitrate dehydrogenase [NADP] cytoplasmic (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase 1) (IDH 1) (IDP 1) (NADP(+)-specific ICDH 1) (Oxalosuccinate decarboxylase 1)",1.08,0.0],["KIRC","Kidney renal clear cell carcinoma","2.30.29.30",21858,"Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein (P-Rex1) (PtdIns(3,4,5)-dependent Rac exchanger 1)",8.184,0.0],["KIRC","Kidney renal clear cell carcinoma","2.60.40.60",18445,"Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin) (VE-cadherin) (CD antigen CD144)",7.206,0.0],["KIRC","Kidney renal clear cell carcinoma","1.10.3500.10",108,"CDNA FLJ31974 fis, clone NT2RP7008167, weakly similar to 85.1 kDa PROTEIN IN GREB-FEOA INTERGENIC REGION",3.894,0.0],["KIRC","Kidney renal clear cell carcinoma","2.60.40.1330",10003,"Fc receptor-like A (Fc receptor homolog expressed in B-cells) (Fc receptor-like and mucin-like protein 1) (Fc receptor-like protein) (Fc receptor-related protein X) (FcRX)",3.794,0.0],["KIRC","Kidney renal clear cell carcinoma","2.60.120.200",24995,"Collagen type V alpha 3 chain (Collagen, type V, alpha 3) (Procollagen, type V, alpha 3, isoform CRA_b) (Protein Col5a3)",3.639,0.0],["KIRC","Kidney renal clear cell carcinoma","2.30.30.30",9070,"60S ribosomal protein L8 (60S ribosomal protein L2)",3.295,0.0],["KIRC","Kidney renal clear cell carcinoma","1.25.40.20",62716,"Ankrd36 protein (Ankyrin-like protein) (MCG14689) (Protein Ankrd36)",2.921,0.00047],["KIRC","Kidney renal clear cell carcinoma","2.160.10.10",81844,"Zinc finger protein 417 (cDNA FLJ58363, highly similar to Zinc finger protein 417)",2.856,0.0],["KIRC","Kidney renal clear cell carcinoma","3.40.532.10",561,"Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1) (Cerebral protein 6)",2.417,0.0],["KIRC","Kidney renal clear cell carcinoma","3.30.800.10",686,"Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (PIPK2 alpha) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(5)P-4-kinase isoform 2-alpha)",2.302,0.0],["KIRC","Kidney renal clear cell carcinoma","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",2.266,0.02174],["KIRC","Kidney renal clear cell carcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.092,0.01015],["KIRC","Kidney renal clear cell carcinoma","1.25.40.70",2223,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine\\/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)",2.066,0.02582],["KIRC","Kidney renal clear cell carcinoma","1.20.1560.10",26709,"Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (MRP-like protein 2) (MLP-2) (Multidrug resistance-associated protein 3)",1.886,0.00971],["KIRC","Kidney renal clear cell carcinoma","3.90.226.10",34071,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)",1.773,0.0076],["KIRC","Kidney renal clear cell carcinoma","1.20.1270.60",4664,"CDNA FLJ52909, highly similar to SH3-containing GRB2-like protein 2 (EC 2.3.1.-)",1.556,0.00047],["KIRC","Kidney renal clear cell carcinoma","2.60.40.780",50,"Von Hippel-Lindau protein (von Hippel-Lindau tumor suppressor)",1.483,0.0],["KIRC","Kidney renal clear cell carcinoma","3.40.50.2000",97317,"CG17323, isoform A (EC 2.4.1.17) (CG17323, isoform C) (EC 2.4.1.17) (CG17323, isoform D) (EC 2.4.1.17) (GH27888p)",1.447,0.00517],["LAML","Acute Myeloid Leukemia","3.40.50.300",629787,"Peroxisomal biogenesis factor 6, isoform CRA_a (cDNA, FLJ94981, highly similar to Homo sapiens peroxisomal biogenesis factor 6 (PEX6), mRNA)",4.9,0.0],["LAML","Acute Myeloid Leukemia","3.30.300.30",32647,"Acyl-coenzyme A synthetase ACSM1, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 1) (Butyrate--CoA ligase 1) (Butyryl-coenzyme A synthetase 1) (Lipoate-activating enzyme) (Middle-chain acyl-CoA synthetase 1) (XL-III) (Xenobiotic\\/medium-chain fatty acid:CoA ligase XL-3) (XM-ligase 3)",4.361,0.0],["LAML","Acute Myeloid Leukemia","1.10.10.750",1186,"USP6 N-terminal-like protein (Related to the N-terminus of tre) (RN-tre)",3.597,0.0],["LAML","Acute Myeloid Leukemia","2.130.10.10",104560,"Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation)",2.997,0.0],["LAML","Acute Myeloid Leukemia","2.60.40.60",18207,"Protocadherin beta-12 (cDNA FLJ55315, highly similar to Protocadherin beta 12) (cDNA, FLJ79059, highly similar to Protocadherin beta 12)",2.973,0.0012],["LAML","Acute Myeloid Leukemia","1.20.1170.10",26222,"Keratin, type II cuticular Hb1 (Hair keratin K2.9) (Keratin, hair, basic, 1) (Keratin-81) (K81) (Metastatic lymph node 137 gene protein) (MLN 137) (Type II hair keratin Hb1) (Type-II keratin Kb21) (ghHKb1) (ghHb1)",2.951,0.0],["LAML","Acute Myeloid Leukemia","1.10.10.10",264994,"Forkhead box protein G1 (Brain factor 1) (BF-1) (BF1) (Brain factor 2) (BF-2) (BF2) (hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1) (HFK1) (Forkhead-related protein FKHL2) (HFK2) (Forkhead-related protein FKHL3) (HFK3)",2.903,0.0],["LAML","Acute Myeloid Leukemia","3.40.50.2000",97281,"Phosphorylase (EC 2.4.1.1)",2.679,0.0],["LAML","Acute Myeloid Leukemia","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.634,0.00024],["LAML","Acute Myeloid Leukemia","1.20.1250.20",178848,"Disrupted in renal carcinoma protein 2 (Disrupted in renal cancer protein 2)",2.464,0.00024],["LAML","Acute Myeloid Leukemia","1.20.120.20",10899,"Perilipin-4 (Adipocyte protein S3-12)",2.094,0.00525],["LAML","Acute Myeloid Leukemia","3.30.230.10",28352,"Fused L13\\/S9 ribosomal protein [Includes: 50S ribosomal protein L13P; 30S ribosomal protein S9P]",2.061,0.0011],["LAML","Acute Myeloid Leukemia","1.10.510.10",78745,"Ret oncogene, isoform A (EC 2.7.10.-) (EC 2.7.10.1) (Ret oncogene, isoform B) (EC 2.7.10.-) (EC 2.7.10.1) (Ret oncogene, isoform C) (EC 2.7.10.-) (EC 2.7.10.1) (Ret oncogene, isoform E) (EC 2.7.10.-) (EC 2.7.10.1)",1.615,0.00477],["LAML","Acute Myeloid Leukemia","3.90.70.10",1887,"Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3)",1.461,0.01496],["LAML","Acute Myeloid Leukemia","2.40.70.10",22885,"Pepsinogen A-13 (EC 3.4.23.1) (Pepsinogen A-19) (EC 3.4.23.1) (Pepsinogen A-41) (EC 3.4.23.1)",1.417,0.0187],["LAML","Acute Myeloid Leukemia","2.40.20.10",1661,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]",1.25,0.0099],["LAML","Acute Myeloid Leukemia","3.40.50.300",630744,"Ras protein let-60 (Abnormal cell lineage protein 34) (Lethal protein 60)",1.146,0.02084],["LAML","Acute Myeloid Leukemia","3.40.718.10",9686,"Isocitrate dehydrogenase [NADP] cytoplasmic (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase 1) (IDH 1) (IDP 1) (NADP(+)-specific ICDH 1) (Oxalosuccinate decarboxylase 1)",1.08,0.02823],["LGG","Low grade gliomas","2.170.300.10",7708,"Neurogenic locus notch homolog protein 1 (Notch gene homolog 1 (Drosophila))",10.91,0.0],["LGG","Low grade gliomas","1.10.30.10",4421,"HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2)",8.837,0.0],["LGG","Low grade gliomas","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",3.532,0.0],["LGG","Low grade gliomas","1.10.510.10",78531,"Raf homolog serine\\/threonine-protein kinase (EC 2.7.11.1) (Abnormal cell lineage protein 45)",3.306,0.0],["LGG","Low grade gliomas","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.82,0.0],["LGG","Low grade gliomas","1.10.510.10",79008,"Calcium\\/calmodulin-dependent protein kinase type II delta 2 chain (EC 2.7.11.17) (Calcium\\/calmodulin-dependent protein kinase type II delta-A chain) (CaM kinase II subunit delta-A) (CaM-kinase II delta-A chain) (CaMK-II subunit delta-A)",2.675,0.0],["LGG","Low grade gliomas","3.40.718.10",9686,"Isocitrate dehydrogenase [NADP] cytoplasmic (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase 1) (IDH 1) (IDP 1) (NADP(+)-specific ICDH 1) (Oxalosuccinate decarboxylase 1)",1.08,0.0],["LIHC","Liver hepatocellular carcinoma","1.10.418.10",4776,"Vav 1 guanine nucleotide exchange factor (Vav 1 oncogene)",3.334,0.0],["LIHC","Liver hepatocellular carcinoma","3.30.710.10",13483,"CDNA FLJ52306, highly similar to Kelch-like protein 1",3.078,0.0],["LIHC","Liver hepatocellular carcinoma","2.60.120.290",8068,"CSMD2 protein",3.055,0.01423],["LIHC","Liver hepatocellular carcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.556,0.0],["LIHC","Liver hepatocellular carcinoma","2.60.40.60",18232,"HCG1982215, isoform CRA_e (Protocadherin gamma subfamily A, 1) (Protocadherin gamma subfamily A, 1, isoform 2)",2.492,0.00488],["LIHC","Liver hepatocellular carcinoma","3.30.60.20",5564,"Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]",2.476,0.01423],["LIHC","Liver hepatocellular carcinoma","1.25.40.70",2223,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine\\/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)",2.4,0.00305],["LIHC","Liver hepatocellular carcinoma","3.20.90.10",495,"Tubby-related protein 2 (Cancer\\/testis antigen 65) (CT65) (Tubby-like protein 2)",1.908,0.00523],["LIHC","Liver hepatocellular carcinoma","2.60.350.10",9563,"Protocadherin gamma B4 (Protocadherin gamma subfamily B, 4)",1.905,0.00523],["LIHC","Liver hepatocellular carcinoma","1.20.1110.10",14781,"Cation-transporting ATPase 13A4 (EC 3.6.3.-) (P5-ATPase isoform 4)",1.858,0.01423],["LIHC","Liver hepatocellular carcinoma","2.60.40.60",18229,"Protocadherin alpha 13 (RCG49388, isoform CRA_c)",1.841,0.02722],["LIHC","Liver hepatocellular carcinoma","3.40.367.20",1728,"Hexokinase-2 (EC 2.7.1.1) (Cytoplasmic antigenic protein 3) (Hexokinase PII) (Hexokinase-B)",1.795,0.01423],["LIHC","Liver hepatocellular carcinoma","3.90.1290.10",1257,"Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)",1.73,0.02876],["LIHC","Liver hepatocellular carcinoma","2.160.10.10",80616,"Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)",1.582,0.00915],["LIHC","Liver hepatocellular carcinoma","3.40.50.970",36536,"Multifunctional 2-oxoglutarate metabolism enzyme (2-hydroxy-3-oxoadipate synthase) (HOA synthase) (HOAS) (EC 2.2.1.5) (2-oxoglutarate carboxy-lyase) (2-oxoglutarate decarboxylase) (Alpha-ketoglutarate decarboxylase) (KG decarboxylase) (KGD) (EC 4.1.1.71) (Alpha-ketoglutarate-glyoxylate carboligase) [Includes: 2-oxoglutarate dehydrogenase E1 component (ODH E1 component) (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase E1 component) (KDH E1 component); Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex E2 component) (ODH E2 component) (OGDC-E2) (Dihydrolipoamide succinyltransferase)]",1.446,0.04555],["LUAD","Lung adenocarcinoma","3.30.40.10",30081,"Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Homologous to ALR protein) (Myeloid\\/lymphoid or mixed-lineage leukemia protein 3)",14.476,0.0],["LUAD","Lung adenocarcinoma","3.30.200.20",1240,"Serine\\/threonine protein kinase BRAF",4.594,0.0],["LUAD","Lung adenocarcinoma","1.20.58.60",16176,"Kalirin isoform 2",3.561,0.0],["LUAD","Lung adenocarcinoma","3.30.200.20",64824,"Epidermal growth factor receptor (Epidermal growth factor receptor isoform 1)",3.22,0.00384],["LUAD","Lung adenocarcinoma","1.10.238.10",33121,"Dystrophin-related protein 2 (RCG38101, isoform CRA_a)",3.218,0.01999],["LUAD","Lung adenocarcinoma","3.10.100.10",12492,"Regenerating islet-derived protein 3-alpha (REG-3-alpha) (Islet of Langerhans regenerating protein 3) (REG 3) (Lithostathine 3) (Pancreatitis-associated protein 2) (RegIII) (Regenerating islet-derived protein III-alpha) (Reg III-alpha) [Cleaved into: Regenerating islet-derived protein 3-alpha 16.5 kDa form; Regenerating islet-derived protein 3-alpha 15 kDa form]",2.971,0.0],["LUAD","Lung adenocarcinoma","2.60.40.10",134685,"Roundabout homolog 3 (Roundabout-like protein 3)",2.927,0.00649],["LUAD","Lung adenocarcinoma","2.60.40.10",136156,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (P230) (Tenascin-C) (TN-C)",2.802,0.01206],["LUAD","Lung adenocarcinoma","2.90.20.10",9453,"Neurogenic locus notch homolog protein 2 (Notch gene homolog 2 (Drosophila), isoform CRA_a)",2.794,0.0287],["LUAD","Lung adenocarcinoma","1.20.1050.10",15561,"HCG19809 (Similar to eukaryotic translation elongation factor 1 beta 2 eukaryotic translation elongation factor 1 beta 1)",2.72,0.00649],["LUAD","Lung adenocarcinoma","2.60.40.10",134913,"Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)",2.671,0.01876],["LUAD","Lung adenocarcinoma","2.20.110.10",8947,"CRE-JPH-1 protein",2.664,0.03084],["LUAD","Lung adenocarcinoma","2.60.40.10",135823,"Fc receptor-like protein 1 (FcR-like protein 1) (FcRL1) (BXMAS1-like protein 1) (mBXMH1) (Fc receptor homolog 1) (FcRH1) (moFcRH1) (IFGP family protein 1) (mIFGP1) (CD antigen CD307a)",2.496,0.01688],["LUAD","Lung adenocarcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.481,0.0],["LUAD","Lung adenocarcinoma","3.40.50.880",33954,"Carbamoyl-phosphate synthase arginine-specific small chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase glutamine chain) (CPS-A)",2.219,0.02202],["LUAD","Lung adenocarcinoma","2.60.40.60",17956,"HCG1982215, isoform CRA_e (Protocadherin gamma subfamily A, 1) (Protocadherin gamma subfamily A, 1, isoform 2)",1.993,0.0],["LUAD","Lung adenocarcinoma","2.60.40.420",23908,"CDNA FLJ61228, highly similar to Hephaestin (EC 1.-.-.-) (cDNA, FLJ79130, highly similar to Hephaestin (EC 1.-.-.-))",1.887,0.04948],["LUAD","Lung adenocarcinoma","2.60.120.200",24567,"Neuronal pentraxin-2 (NP2) (Acrosomal pentaxin-like protein p50) (AM50) (Neuronal pentraxin II) (Apexin) (NP-II)",1.881,0.03919],["LUAD","Lung adenocarcinoma","2.60.40.60",18229,"Protocadherin alpha 13 (RCG49388, isoform CRA_c)",1.872,0.0],["LUAD","Lung adenocarcinoma","2.60.40.60",18149,"Pcdha6 protein (Protocadherin alpha 6)",1.859,0.0],["LUAD","Lung adenocarcinoma","1.10.510.10",79228,"Calcium\\/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium\\/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha)",1.735,0.02202],["LUAD","Lung adenocarcinoma","1.10.510.10",79008,"Calcium\\/calmodulin-dependent protein kinase type II delta 2 chain (EC 2.7.11.17) (Calcium\\/calmodulin-dependent protein kinase type II delta-A chain) (CaM kinase II subunit delta-A) (CaM-kinase II delta-A chain) (CaMK-II subunit delta-A)",1.715,0.01738],["LUAD","Lung adenocarcinoma","3.20.20.70",120783,"4-hydroxy-2-oxovalerate aldolase (HOA) (EC 4.1.3.39) (4-hydroxy-2-keto-pentanoic acid aldolase) (4-hydroxy-2-oxohexanoate aldolase) (EC 4.1.3.n1) (4-hydroxy-2-oxopentanoate aldolase)",1.705,0.01738],["LUAD","Lung adenocarcinoma","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",1.686,0.0211],["LUAD","Lung adenocarcinoma","3.90.1290.10",1257,"Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)",1.601,0.00384],["LUAD","Lung adenocarcinoma","2.60.40.10",136000,"CMRF35-like molecule 7 (CLM-7) (CD300 antigen-like family member B) (CMRF35-A2) (Immune receptor expressed on myeloid cells 3) (IREM-3) (Leukocyte mono-Ig-like receptor 5) (Triggering receptor expressed on myeloid cells 5) (TREM-5) (CD antigen CD300b)",1.509,0.03907],["LUAD","Lung adenocarcinoma","3.40.930.10",4542,"Anion exchange protein 3 (AE 3) (Anion exchanger 3) (Band 3-related protein 3) (B3RP-3) (Neuronal band 3-like protein) (Solute carrier family 4 member 3)",1.505,0.02286],["LUAD","Lung adenocarcinoma","3.40.50.1820",115488,"Pancreatic lipase-related protein 2 (PL-RP2) (EC 3.1.1.26) (EC 3.1.1.3) (Cytotoxic T-lymphocyte lipase) (Galactolipase)",1.219,0.02202],["LUAD","Lung adenocarcinoma","3.40.50.300",630744,"Ras protein let-60 (Abnormal cell lineage protein 34) (Lethal protein 60)",1.129,0.0],["LUSC","Lung squamous cell carcinoma","2.20.100.10",10006,"A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM metallopeptidase with thrombospondin type 1 motif, 20, isoform CRA_c)",3.466,0.00596],["LUSC","Lung squamous cell carcinoma","3.10.100.10",12492,"Regenerating islet-derived protein 3-alpha (REG-3-alpha) (Islet of Langerhans regenerating protein 3) (REG 3) (Lithostathine 3) (Pancreatitis-associated protein 2) (RegIII) (Regenerating islet-derived protein III-alpha) (Reg III-alpha) [Cleaved into: Regenerating islet-derived protein 3-alpha 16.5 kDa form; Regenerating islet-derived protein 3-alpha 15 kDa form]",3.321,0.0],["LUSC","Lung squamous cell carcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.606,0.0],["LUSC","Lung squamous cell carcinoma","2.130.10.10",102894,"F-box\\/WD repeat-containing protein sel-10 (Egg laying defective protein 41) (Suppressor\\/enhancer of lin-12 protein 10)",2.6,0.0],["LUSC","Lung squamous cell carcinoma","2.60.40.60",18435,"HCG1982215, isoform CRA_e (Protocadherin gamma subfamily A, 1) (Protocadherin gamma subfamily A, 1, isoform 2)",2.359,0.02527],["LUSC","Lung squamous cell carcinoma","3.40.50.410",19689,"Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)",2.229,0.03422],["LUSC","Lung squamous cell carcinoma","2.60.350.10",9520,"CDH7 protein",2.218,0.04711],["LUSC","Lung squamous cell carcinoma","2.60.40.10",135012,"Opioid binding protein\\/cell adhesion molecule-like isoform c (Opioid-binding protein\\/cell adhesion molecule) (cDNA, FLJ79390, highly similar to Opioid-binding protein\\/cell adhesion molecule)",2.198,0.03128],["LUSC","Lung squamous cell carcinoma","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",2.196,0.0],["LUSC","Lung squamous cell carcinoma","1.25.40.70",2223,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine\\/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)",2.1,0.00463],["LUSC","Lung squamous cell carcinoma","3.30.420.40",77117,"Actin alpha 1 skeletal muscle protein",2.077,0.01911],["LUSC","Lung squamous cell carcinoma","2.60.120.40",2614,"Complement C1q and tumor necrosis factor-related protein 9B (C1q\\/TNF-related protein 9B) (CTRP9B) (Complement C1q and tumor necrosis factor-related protein 9-like)",2.06,0.03649],["LUSC","Lung squamous cell carcinoma","3.30.420.40",78983,"Actin related protein 1",1.995,0.02527],["LUSC","Lung squamous cell carcinoma","2.60.40.60",18149,"Pcdha6 protein (Protocadherin alpha 6)",1.967,0.03649],["LUSC","Lung squamous cell carcinoma","3.80.10.10",105911,"LRRTM4 protein (Leucine-rich repeat transmembrane neuronal protein 4)",1.897,0.03649],["LUSC","Lung squamous cell carcinoma","2.60.40.60",18207,"Protocadherin beta-12 (cDNA FLJ55315, highly similar to Protocadherin beta 12) (cDNA, FLJ79059, highly similar to Protocadherin beta 12)",1.774,0.02527],["LUSC","Lung squamous cell carcinoma","2.160.10.10",82034,"Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)",1.67,0.03843],["LUSC","Lung squamous cell carcinoma","3.10.200.10",1430,"Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I)",1.585,0.00278],["OV","Ovarian serous cystadenocarcinoma","2.60.40.60",18207,"Protocadherin beta-12 (cDNA FLJ55315, highly similar to Protocadherin beta 12) (cDNA, FLJ79059, highly similar to Protocadherin beta 12)",2.919,0.0015],["OV","Ovarian serous cystadenocarcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.79,0.0],["OV","Ovarian serous cystadenocarcinoma","2.60.120.260",35252,"Ephrin type-B receptor 2 (EC 2.7.10.1) (Neural kinase) (Nuk receptor tyrosine kinase) (Tyrosine-protein kinase receptor EPH-3) (Tyrosine-protein kinase receptor SEK-3)",2.38,0.012],["OV","Ovarian serous cystadenocarcinoma","2.60.120.10",54809,"Cyclic nucleotide-gated cation channel beta-1 (240 kDa protein of rod photoreceptor CNG-channel) (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP)",2.127,0.004],["OV","Ovarian serous cystadenocarcinoma","3.40.630.10",34847,"Adipocyte enhancer-binding protein 1 (AE-binding protein 1) (Aortic carboxypeptidase-like protein)",1.66,0.012],["OV","Ovarian serous cystadenocarcinoma","2.60.40.1400",477,"ATP-sensitive inward rectifier potassium channel 10 (ATP-sensitive inward rectifier potassium channel KAB-2) (BIR10) (Brain-specific inwardly rectifying K(+) channel 1) (BIRK1) (Inward rectifier K(+) channel Kir4.1) (Potassium channel, inwardly rectifying subfamily J member 10)",1.614,0.042],["PAAD","Pancreatic adenocarcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.71,0.0],["PAAD","Pancreatic adenocarcinoma","1.25.10.10",68666,"Splicing factor 3B subunit 1 (146 kDa nuclear protein) (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)",2.284,0.00648],["PAAD","Pancreatic adenocarcinoma","1.10.510.10",78763,"EG:132E8.2 protein (FI03728p) (SNF1A\\/AMP-activated protein kinase) (SNF1A\\/AMP-activated protein kinase, isoform A) (EC 2.7.11.-) (EC 2.7.11.16) (SNF1A\\/AMP-activated protein kinase, isoform B) (EC 2.7.11.-) (EC 2.7.11.16) (SNF1A\\/AMP-activated protein kinase, isoform C) (EC 2.7.11.-) (EC 2.7.11.16)",2.209,0.0027],["PAAD","Pancreatic adenocarcinoma","2.60.200.10",492,"Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4 homolog) (SMAD family member 4) (SMAD 4) (Smad4)",1.888,0.0],["PAAD","Pancreatic adenocarcinoma","3.40.50.10810",9053,"Transcription regulatory protein SNF2 (EC 3.6.4.-) (ATP-dependent helicase SNF2) (Regulatory protein GAM1) (Regulatory protein SWI2) (SWI\\/SNF complex component SNF2) (Transcription factor TYE3)",1.836,0.03857],["PAAD","Pancreatic adenocarcinoma","2.140.10.30",11540,"Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)]",1.491,0.0282],["PAAD","Pancreatic adenocarcinoma","3.40.50.300",630744,"Ras protein let-60 (Abnormal cell lineage protein 34) (Lethal protein 60)",1.146,0.0],["PRAD","Prostate adenocarcinoma","2.60.40.60",18201,"Pcdha6 protein (Protocadherin alpha 6)",2.942,0.0],["PRAD","Prostate adenocarcinoma","2.60.210.10",2360,"TNF receptor-associated factor 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)",2.726,0.0],["PRAD","Prostate adenocarcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.568,0.0],["PRAD","Prostate adenocarcinoma","3.10.200.10",1430,"Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I)",1.553,0.03045],["READ","Rectum adenocarcinoma","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",2.758,0.0],["READ","Rectum adenocarcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.627,0.0],["READ","Rectum adenocarcinoma","1.10.10.10",264994,"Forkhead box protein G1 (Brain factor 1) (BF-1) (BF1) (Brain factor 2) (BF-2) (BF2) (hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1) (HFK1) (Forkhead-related protein FKHL2) (HFK2) (Forkhead-related protein FKHL3) (HFK3)",2.52,0.00974],["READ","Rectum adenocarcinoma","2.130.10.10",102894,"F-box\\/WD repeat-containing protein sel-10 (Egg laying defective protein 41) (Suppressor\\/enhancer of lin-12 protein 10)",2.189,0.0],["READ","Rectum adenocarcinoma","2.60.350.10",9563,"Protocadherin gamma B4 (Protocadherin gamma subfamily B, 4)",2.185,0.00974],["READ","Rectum adenocarcinoma","3.90.190.10",11605,"Dual specificity protein phosphatase 4 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2) (MAP kinase phosphatase 2) (MKP-2)",2.105,0.00974],["READ","Rectum adenocarcinoma","1.10.510.10",78531,"Raf homolog serine\\/threonine-protein kinase (EC 2.7.11.1) (Abnormal cell lineage protein 45)",2.02,0.03772],["READ","Rectum adenocarcinoma","1.20.900.10",3381,"Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor) (p190-RhoGEF) (p190RhoGEF) (Rho guanine nucleotide exchange factor) (Rho-interacting protein 2)",1.941,0.04483],["READ","Rectum adenocarcinoma","2.60.40.60",18207,"Protocadherin beta-12 (cDNA FLJ55315, highly similar to Protocadherin beta 12) (cDNA, FLJ79059, highly similar to Protocadherin beta 12)",1.879,0.02893],["READ","Rectum adenocarcinoma","2.60.200.10",492,"Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4 homolog) (SMAD family member 4) (SMAD 4) (Smad4)",1.762,0.0124],["READ","Rectum adenocarcinoma","1.10.1070.11",1687,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine\\/threonine protein kinase PIK3CA) (EC 2.7.11.1)",1.66,0.03772],["READ","Rectum adenocarcinoma","1.10.510.10",78946,"Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3)",1.53,0.03772],["READ","Rectum adenocarcinoma","3.40.50.300",630744,"Ras protein let-60 (Abnormal cell lineage protein 34) (Lethal protein 60)",1.133,0.0],["SKCM","Skin Cutaneous Melanoma","1.10.418.10",1403,"Nesprin-1 (Enaptin) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1)",9.195,0.0],["SKCM","Skin Cutaneous Melanoma","3.40.50.300",45731,"Protein AK9",6.019,0.0],["SKCM","Skin Cutaneous Melanoma","2.60.40.10",20362,"Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)",4.893,0.0],["SKCM","Skin Cutaneous Melanoma","2.60.350.10",2575,"Protocadherin-23 (Cadherin-27) (Cadherin-like protein CDHJ) (Cadherin-like protein VR8) (Protein dachsous homolog 2) (Protocadherin PCDHJ)",4.709,0.0],["SKCM","Skin Cutaneous Melanoma","2.20.100.10",9715,"A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM metallopeptidase with thrombospondin type 1 motif, 20, isoform CRA_c)",4.675,0.0],["SKCM","Skin Cutaneous Melanoma","2.60.40.60",18619,"Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)",4.42,0.0],["SKCM","Skin Cutaneous Melanoma","2.160.20.50",291,"Collagen alpha-1(XIV) chain (Undulin)",4.175,0.00581],["SKCM","Skin Cutaneous Melanoma","2.40.20.10",1589,"Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain]",3.677,0.0],["SKCM","Skin Cutaneous Melanoma","2.60.40.10",134821,"Interleukin-1 receptor-like 1 (Lymphocyte antigen 84) (Protein ST2) (Protein T1)",3.034,0.00899],["SKCM","Skin Cutaneous Melanoma","2.60.40.150",3540,"MCTP1 protein",3.015,0.00697],["SKCM","Skin Cutaneous Melanoma","1.10.510.10",78531,"Raf homolog serine\\/threonine-protein kinase (EC 2.7.11.1) (Abnormal cell lineage protein 45)",2.972,0.0],["SKCM","Skin Cutaneous Melanoma","2.60.350.10",2781,"Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)",2.891,0.0119],["SKCM","Skin Cutaneous Melanoma","2.60.40.1330",10136,"Cell adhesion molecule-related\\/down-regulated by oncogenes",2.86,0.0],["SKCM","Skin Cutaneous Melanoma","2.160.20.50",17805,"Collagen triple helix repeat-containing protein (Collagen-like protein 4)",2.851,0.0119],["SKCM","Skin Cutaneous Melanoma","3.30.40.10",59876,"E3 ubiquitin-protein ligase CBL-B (EC 6.3.2.-) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)",2.821,0.01584],["SKCM","Skin Cutaneous Melanoma","2.60.40.10",54221,"Carcinoembryonic antigen-related cell adhesion molecule 20 variant 5S",2.793,0.0119],["SKCM","Skin Cutaneous Melanoma","1.50.10.10",18716,"Glycoside hydrolase family protein 65, central catalytic",2.792,0.0],["SKCM","Skin Cutaneous Melanoma","2.60.40.60",17984,"HCG1982215, isoform CRA_e (Protocadherin gamma subfamily A, 1) (Protocadherin gamma subfamily A, 1, isoform 2)",2.729,0.0],["SKCM","Skin Cutaneous Melanoma","2.90.20.10",9329,"Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)",2.724,0.01494],["SKCM","Skin Cutaneous Melanoma","2.30.42.10",23883,"CRE-MAGI-1 protein",2.695,0.01056],["SKCM","Skin Cutaneous Melanoma","3.40.50.2300",28047,"Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3) (GluA3)",2.622,0.01849],["SKCM","Skin Cutaneous Melanoma","2.20.110.10",8947,"CRE-JPH-1 protein",2.614,0.0119],["SKCM","Skin Cutaneous Melanoma","2.20.100.10",10057,"Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B) (p53-regulated receptor for death and life protein 1)",2.591,0.0],["SKCM","Skin Cutaneous Melanoma","2.60.40.10",32936,"HERV-H LTR-associating protein 2 (Human endogenous retrovirus-H long terminal repeat-associating protein 2)",2.561,0.0119],["SKCM","Skin Cutaneous Melanoma","3.30.565.10",80822,"Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)",2.549,0.04182],["SKCM","Skin Cutaneous Melanoma","2.160.10.10",80308,"Zinc finger protein 615",2.464,0.00697],["SKCM","Skin Cutaneous Melanoma","2.90.20.10",1779,"Protein kinase C-binding protein NELL1 (NEL-like protein 1) (Nel-related protein 1)",2.394,0.02835],["SKCM","Skin Cutaneous Melanoma","2.60.40.10",134415,"Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)",2.359,0.03253],["SKCM","Skin Cutaneous Melanoma","1.10.10.60",123191,"Intestine-specific homeobox (RAX-like homeobox)",2.356,0.00697],["SKCM","Skin Cutaneous Melanoma","4.10.400.10",12137,"Low-density lipoprotein receptor-related protein 3 (LRP-3) (105 kDa low-density lipoprotein receptor-related protein) (hLRp105)",2.355,0.04647],["SKCM","Skin Cutaneous Melanoma","2.160.10.10",43047,"Zinc finger protein 560",2.351,0.04066],["SKCM","Skin Cutaneous Melanoma","3.40.525.10",3462,"Trio protein",2.304,0.00697],["SKCM","Skin Cutaneous Melanoma","1.20.120.330",23900,"Cingulin-like protein 1 (Junction-associated coiled-coil protein) (Paracingulin)",2.303,0.03998],["SKCM","Skin Cutaneous Melanoma","2.160.20.50",17104,"Collectin-10 (Collectin liver protein 1) (CL-L1) (Collectin-34) (CL-34)",2.289,0.01818],["SKCM","Skin Cutaneous Melanoma","2.60.40.10",12028,"Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho)",2.278,0.01936],["SKCM","Skin Cutaneous Melanoma","2.60.40.10",136156,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (P230) (Tenascin-C) (TN-C)",2.258,0.0386],["SKCM","Skin Cutaneous Melanoma","1.10.150.120",3036,"Xanthine dehydrogenase\\/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]",2.233,0.01877],["SKCM","Skin Cutaneous Melanoma","2.10.70.10",16440,"CFHR3 protein (Complement factor H-related 3, isoform CRA_c) (Complement factor H-related protein 3)",2.198,0.03907],["SKCM","Skin Cutaneous Melanoma","2.130.10.10",102894,"F-box\\/WD repeat-containing protein sel-10 (Egg laying defective protein 41) (Suppressor\\/enhancer of lin-12 protein 10)",2.179,0.0],["SKCM","Skin Cutaneous Melanoma","3.30.460.10",17944,"2,5-oligoadenylate synthetase-like 5 (2-5 oligoadenylate synthetase 1C) (2-5 olygoadenylate synthetase 1c) (MCG16011, isoform CRA_b) (Protein Oas1c)",2.17,0.01877],["SKCM","Skin Cutaneous Melanoma","2.30.29.30",21844,"Gamma-2-syntrophin (G2SYN) (Syntrophin-5) (SYN5)",2.107,0.02764],["SKCM","Skin Cutaneous Melanoma","1.20.1170.10",4932,"Envoplakin (210 kDa cornified envelope precursor protein) (210 kDa paraneoplastic pemphigus antigen) (p210)",2.03,0.0425],["SKCM","Skin Cutaneous Melanoma","2.160.10.10",82224,"Zinc finger protein 711 (Zinc finger protein 6)",1.993,0.00367],["SKCM","Skin Cutaneous Melanoma","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",1.972,0.0],["SKCM","Skin Cutaneous Melanoma","1.10.10.60",124216,"Homeobox protein Nkx-2.3 (Homeobox protein NK-2 homolog 3) (Homeobox protein NK-2 homolog C) (Nkx2-C)",1.967,0.0119],["SKCM","Skin Cutaneous Melanoma","1.10.1450.10",2060,"Tetraspanin-8 (Tspan-8) (Transmembrane 4 superfamily member 3) (Tumor-associated antigen CO-029)",1.94,0.04066],["SKCM","Skin Cutaneous Melanoma","2.60.120.200",24567,"Neuronal pentraxin-2 (NP2) (Acrosomal pentaxin-like protein p50) (AM50) (Neuronal pentraxin II) (Apexin) (NP-II)",1.933,0.0],["SKCM","Skin Cutaneous Melanoma","1.20.1250.20",179241,"Solute carrier family 46 member 3",1.889,0.04807],["SKCM","Skin Cutaneous Melanoma","2.10.25.10",45828,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (P230) (Tenascin-C) (TN-C)",1.888,0.04066],["SKCM","Skin Cutaneous Melanoma","3.40.50.2300",150735,"Glutamate receptor ionotropic, kainate 4 (GluK4) (Excitatory amino acid receptor 1) (EAA1) (Glutamate receptor KA-1) (KA1)",1.859,0.04182],["SKCM","Skin Cutaneous Melanoma","1.20.120.350",4263,"Potassium voltage-gated channel subfamily C member 1 (NGK2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4)",1.854,0.04106],["SKCM","Skin Cutaneous Melanoma","3.80.10.10",106957,"Leucine-rich repeat neuronal protein 4 (Neuronal leucine-rich repeat protein 4) (NLRR-4)",1.842,0.03428],["SKCM","Skin Cutaneous Melanoma","2.60.40.1110",438,"Formin-like protein 3 (OsFH3)",1.828,0.00581],["SKCM","Skin Cutaneous Melanoma","1.10.287.110",14410,"DnaJ homolog subfamily C member 5B (Cysteine string protein beta) (CSP-beta)",1.815,0.04782],["SKCM","Skin Cutaneous Melanoma","2.160.10.10",81861,"Zinc finger protein 585B (zinc finger protein 41-like protein)",1.775,0.04756],["SKCM","Skin Cutaneous Melanoma","2.60.120.200",24615,"Contactin-associated protein-like 2 (Cell recognition molecule Caspr2)",1.759,0.0354],["SKCM","Skin Cutaneous Melanoma","2.60.120.290",8045,"CSMD2 protein",1.726,0.02568],["SKCM","Skin Cutaneous Melanoma","1.20.5.340",4277,"Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx\\/d) (MyHC-IIx\\/d) (Myosin heavy chain, skeletal muscle, adult 1)",1.723,0.0119],["SKCM","Skin Cutaneous Melanoma","2.60.40.1330",9715,"Netrin receptor DCC (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC)",1.686,0.01818],["SKCM","Skin Cutaneous Melanoma","1.20.5.340",4317,"Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx\\/d) (MyHC-IIx\\/d) (Myosin heavy chain, skeletal muscle, adult 1)",1.639,0.00581],["SKCM","Skin Cutaneous Melanoma","2.60.40.10",133288,"Leukocyte immunoglobulin-like receptor subfamily B member 1 (LIR-1) (Leukocyte immunoglobulin-like receptor 1) (CD85 antigen-like family member J) (Immunoglobulin-like transcript 2) (ILT-2) (Monocyte\\/macrophage immunoglobulin-like receptor 7) (MIR-7) (CD antigen CD85j)",1.625,0.01056],["SKCM","Skin Cutaneous Melanoma","3.90.215.10",2905,"Angiopoietin-4 (Angiopoietin-like protein 4)",1.619,0.0119],["SKCM","Skin Cutaneous Melanoma","3.30.420.40",79206,"Hexokinase-2 (EC 2.7.1.1) (Cytoplasmic antigenic protein 3) (Hexokinase PII) (Hexokinase-B)",1.58,0.0386],["SKCM","Skin Cutaneous Melanoma","2.130.10.10",103908,"Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF\\/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)",1.572,0.0],["SKCM","Skin Cutaneous Melanoma","1.20.1270.60",4610,"Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1)",1.545,0.04144],["SKCM","Skin Cutaneous Melanoma","1.20.5.170",18295,"Keratin, type II cuticular Hb4 (65 kDa type II keratin) (Keratin-84) (K84) (Type II hair keratin Hb4) (Type-II keratin Kb24)",1.528,0.00581],["SKCM","Skin Cutaneous Melanoma","2.80.10.50",8671,"Interleukin-36 beta (FIL1 eta) (Interleukin-1 eta) (IL-1 eta) (Interleukin-1 family member 8) (IL-1F8) (Interleukin-1 homolog 2) (IL-1H2)",1.519,0.00697],["SKCM","Skin Cutaneous Melanoma","2.60.40.60",18232,"HCG1982215, isoform CRA_e (Protocadherin gamma subfamily A, 1) (Protocadherin gamma subfamily A, 1, isoform 2)",1.515,0.04182],["SKCM","Skin Cutaneous Melanoma","3.10.100.10",12492,"Regenerating islet-derived protein 3-alpha (REG-3-alpha) (Islet of Langerhans regenerating protein 3) (REG 3) (Lithostathine 3) (Pancreatitis-associated protein 2) (RegIII) (Regenerating islet-derived protein III-alpha) (Reg III-alpha) [Cleaved into: Regenerating islet-derived protein 3-alpha 16.5 kDa form; Regenerating islet-derived protein 3-alpha 15 kDa form]",1.477,0.04216],["SKCM","Skin Cutaneous Melanoma","3.40.30.10",79844,"Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.-) (Antioxidant protein 2) (Non-selenium glutathione peroxidase) (NSGPx) (EC 1.11.1.9) (Thiol-specific antioxidant protein)",1.468,0.04182],["SKCM","Skin Cutaneous Melanoma","3.90.1290.10",1257,"Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)",1.462,0.00697],["SKCM","Skin Cutaneous Melanoma","2.60.40.60",18229,"Protocadherin alpha 13 (RCG49388, isoform CRA_c)",1.412,0.02028],["SKCM","Skin Cutaneous Melanoma","3.40.50.200",10272,"Proprotein convertase subtilisin\\/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin\\/kexin-like protease PC7)",1.392,0.01877],["SKCM","Skin Cutaneous Melanoma","2.60.350.10",9563,"Protocadherin gamma B4 (Protocadherin gamma subfamily B, 4)",1.39,0.01936],["SKCM","Skin Cutaneous Melanoma","3.10.200.10",1430,"Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I)",1.36,0.0],["SKCM","Skin Cutaneous Melanoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",1.343,0.03485],["SKCM","Skin Cutaneous Melanoma","2.60.40.10",137567,"Pregnancy-specific beta-1-glycoprotein 9 (PS-beta-G-9) (PSBG-9) (Pregnancy-specific glycoprotein 9) (PS34) (Pregnancy-specific beta-1 glycoprotein B) (PS-beta-B) (Pregnancy-specific beta-1-glycoprotein 11) (PS-beta-G-11) (PSBG-11) (Pregnancy-specific glycoprotein 11) (Pregnancy-specific glycoprotein 7) (PSG7)",1.319,0.04182],["SKCM","Skin Cutaneous Melanoma","3.30.500.10",3472,"T-cell surface glycoprotein CD1e, membrane-associated (hCD1e) (R2G1) (CD antigen CD1e) [Cleaved into: T-cell surface glycoprotein CD1e, soluble (sCD1e)]",1.278,0.02568],["SKCM","Skin Cutaneous Melanoma","1.50.10.10",18715,"Edem1, isoform A (EC 3.2.1.113) (Edem1, isoform B) (EC 3.2.1.113) (Edem1, isoform C) (EC 3.2.1.113) (Edem1, isoform D) (EC 3.2.1.113) (GH14693p) (LD21416p)",1.246,0.04066],["SKCM","Skin Cutaneous Melanoma","3.40.50.300",623830,"Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1)",1.23,0.03998],["SKCM","Skin Cutaneous Melanoma","3.40.33.10",4816,"CRISP2 protein (Cysteine-rich secretory protein 2, isoform CRA_a) (Testis-specific protein TPX1 b isoform) (Testis-specific protein TPX1 d isoform) (Testis-specific protein TPX1 e isoform)",1.222,0.04535],["SKCM","Skin Cutaneous Melanoma","3.90.550.10",64971,"Polypeptide N-acetylgalactosaminyltransferase 16 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 1) (GalNAc-T-like protein 1) (pp-GaNTase-like protein 1) (Polypeptide N-acetylgalactosaminyltransferase-like protein 1) (Protein-UDP acetylgalactosaminyltransferase-like protein 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1)",1.182,0.01849],["SKCM","Skin Cutaneous Melanoma","3.40.630.10",34847,"Adipocyte enhancer-binding protein 1 (AE-binding protein 1) (Aortic carboxypeptidase-like protein)",1.175,0.04182],["SKCM","Skin Cutaneous Melanoma","3.40.50.2000",97317,"CG17323, isoform A (EC 2.4.1.17) (CG17323, isoform C) (EC 2.4.1.17) (CG17323, isoform D) (EC 2.4.1.17) (GH27888p)",1.142,0.01849],["SKCM","Skin Cutaneous Melanoma","3.40.50.300",629994,"Ras-related C3 botulinum toxin substrate 1 (Rho family, small GTP binding protein Rac1) (Ras-related C3 botulinum toxin substrate 1 (Rho family, small GTP binding protein Rac1), isoform CRA_e) (cDNA FLJ77333, highly similar to Homo sapiens ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) (RAC1), transcript variant Rac1b, mRNA)",1.126,0.01584],["SKCM","Skin Cutaneous Melanoma","3.40.50.300",630744,"Ras protein let-60 (Abnormal cell lineage protein 34) (Lethal protein 60)",1.109,0.0],["SKCM","Skin Cutaneous Melanoma","1.10.630.10",29314,"Cytochrome P450 family 3 subfamily A polypeptide 4 (Cytochrome P450, family 3, subfamily A, polypeptide 4) (Cytochrome P450, family 3, subfamily A, polypeptide 4, isoform CRA_a) (Cytochrome P450, subfamily IIIA, polypeptide 4) (cDNA, FLJ93427, Homo sapiens cytochrome P450, family 3, subfamily A, polypeptide 4(CYP3A4), transcript variant 1, mRNA)",1.051,0.00581],["STAD","Stomach adenocarcinoma","2.130.10.10",102894,"F-box\\/WD repeat-containing protein sel-10 (Egg laying defective protein 41) (Suppressor\\/enhancer of lin-12 protein 10)",2.573,0.0],["STAD","Stomach adenocarcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.519,0.0],["STAD","Stomach adenocarcinoma","1.10.30.10",4396,"Sex-determining region Y protein (Testis-determining factor)",2.472,0.0],["STAD","Stomach adenocarcinoma","3.40.120.10",16736,"Phosphoglucomutase (PGM) (EC 5.4.2.2) (Glucose phosphomutase)",2.311,0.0],["STAD","Stomach adenocarcinoma","2.60.200.10",492,"Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4 homolog) (SMAD family member 4) (SMAD 4) (Smad4)",2.218,0.0],["STAD","Stomach adenocarcinoma","2.60.40.60",17956,"HCG1982215, isoform CRA_e (Protocadherin gamma subfamily A, 1) (Protocadherin gamma subfamily A, 1, isoform 2)",2.205,0.00351],["STAD","Stomach adenocarcinoma","1.10.10.60",124590,"POU class 1 homeobox 1 (Pituitary-specific positive transcription factor 1)",2.034,0.03747],["STAD","Stomach adenocarcinoma","1.20.120.350",4260,"Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)",1.973,0.02208],["STAD","Stomach adenocarcinoma","1.10.10.60",123467,"Homeobox protein Hox-D4 (Homeobox protein HHO.C13) (Homeobox protein Hox-4B) (Homeobox protein Hox-5.1)",1.965,0.0],["STAD","Stomach adenocarcinoma","1.10.10.60",124216,"Homeobox protein Nkx-2.3 (Homeobox protein NK-2 homolog 3) (Homeobox protein NK-2 homolog C) (Nkx2-C)",1.955,0.01405],["STAD","Stomach adenocarcinoma","1.10.10.10",264994,"Forkhead box protein G1 (Brain factor 1) (BF-1) (BF1) (Brain factor 2) (BF-2) (BF2) (hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1) (HFK1) (Forkhead-related protein FKHL2) (HFK2) (Forkhead-related protein FKHL3) (HFK3)",1.933,0.0],["STAD","Stomach adenocarcinoma","3.40.50.2300",150845,"Glutamate receptor ionotropic, kainate 3 (Glutamate receptor, ionotropic, kainate 3, isoform CRA_a) (Glutamate\\/kainate receptor subtype GluR7)",1.738,0.00562],["STAD","Stomach adenocarcinoma","2.60.40.60",18229,"Protocadherin alpha 13 (RCG49388, isoform CRA_c)",1.694,0.00766],["STAD","Stomach adenocarcinoma","2.60.40.60",18149,"Pcdha6 protein (Protocadherin alpha 6)",1.686,0.01729],["STAD","Stomach adenocarcinoma","2.60.40.60",18207,"Protocadherin beta-12 (cDNA FLJ55315, highly similar to Protocadherin beta 12) (cDNA, FLJ79059, highly similar to Protocadherin beta 12)",1.679,0.00562],["THCA","Thyroid carcinoma","1.10.10.750",1186,"USP6 N-terminal-like protein (Related to the N-terminus of tre) (RN-tre)",7.644,0.0],["THCA","Thyroid carcinoma","2.160.10.10",80228,"Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)",7.369,0.0],["THCA","Thyroid carcinoma","1.10.510.10",78531,"Raf homolog serine\\/threonine-protein kinase (EC 2.7.11.1) (Abnormal cell lineage protein 45)",3.279,0.0],["THCA","Thyroid carcinoma","2.60.40.60",17929,"Protocadherin beta-12 (cDNA FLJ55315, highly similar to Protocadherin beta 12) (cDNA, FLJ79059, highly similar to Protocadherin beta 12)",2.947,0.0],["THCA","Thyroid carcinoma","2.60.40.10",16275,"Immunoglobulin superfamily member 3 (IgSF3) (Glu-Trp-Ile EWI motif-containing protein 3) (EWI-3)",2.937,0.00338],["THCA","Thyroid carcinoma","3.10.320.10",3775,"MHC class I antigen (MHC class II DR alpha chain) (MHC class II antigen) (MHC class II antigen DR alpha chain)",2.6,0.0],["THCA","Thyroid carcinoma","3.90.1290.10",1257,"Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)",1.799,0.02754],["THCA","Thyroid carcinoma","3.40.140.10",13208,"DNA dC->dU-editing enzyme APOBEC-3H (EC 3.5.4.-) (APOBEC-related protein 10) (ARP-10) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3H) (A3H)",1.605,0.0228],["THCA","Thyroid carcinoma","3.10.320.10",2577,"HLA class II histocompatibility antigen, DQ beta 1 chain (MHC class II antigen DQB1)",1.556,0.03657],["THCA","Thyroid carcinoma","1.20.1080.10",5095,"Glycerol uptake facilitator protein (MIP family channel protein)",1.187,0.0018],["THCA","Thyroid carcinoma","3.40.50.300",630744,"Ras protein let-60 (Abnormal cell lineage protein 34) (Lethal protein 60)",1.146,0.00338],["UCEC","Uterine Corpus Endometrial Carcinoma","2.60.40.10",135017,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",6.981,0.0],["UCEC","Uterine Corpus Endometrial Carcinoma","3.40.50.300",45731,"Protein AK9",5.732,0.0],["UCEC","Uterine Corpus Endometrial Carcinoma","3.30.420.10",44795,"DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase 2 a) (AtPOL2a) (DNA polymerase II subunit a) (Protein ABA OVERLY SENSITIVE a) (Protein EARLY IN SHORT DAYS 7) (Protein EMBRYO DEFECTIVE 142) (Protein EMBRYO DEFECTIVE 2284) (Protein EMBRYO DEFECTIVE 529) (Protein TILTED 1)",5.638,0.0],["UCEC","Uterine Corpus Endometrial Carcinoma","2.30.42.10",23883,"CRE-MAGI-1 protein",4.176,0.00315],["UCEC","Uterine Corpus Endometrial Carcinoma","3.90.190.10",11707,"IP16020p (Phosphatase PTEN) (Pten, isoform B) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform D) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform G) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Pten, isoform H) (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67)",3.61,0.0],["UCEC","Uterine Corpus Endometrial Carcinoma","2.160.10.10",31282,"Zinc finger protein 560",3.498,0.00682],["UCEC","Uterine Corpus Endometrial Carcinoma","2.60.40.10",22365,"Mdga2 protein",3.319,0.00315],["UCEC","Uterine Corpus Endometrial Carcinoma","1.20.120.330",23932,"Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)",3.317,0.0],["UCEC","Uterine Corpus Endometrial Carcinoma","2.160.10.10",79658,"Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein) (Cancer\\/testis antigen 27) (CT27) (Zinc finger protein CTCF-T)",3.177,0.00861],["UCEC","Uterine Corpus Endometrial Carcinoma","3.30.505.10",4288,"Signaling lymphocytic activation molecule-associated protein",3.062,0.00481],["UCEC","Uterine Corpus Endometrial Carcinoma","3.40.850.10",4714,"Kinesin-related protein SMY1 (Suppressor protein SMY1)",2.864,0.0],["UCEC","Uterine Corpus Endometrial Carcinoma","3.30.470.20",30849,"Synapsin-1 (Brain protein 4.1) (Synapsin I)",2.759,0.01363],["UCEC","Uterine Corpus Endometrial Carcinoma","1.10.1000.11",916,"CRE-EFA-6 protein",2.637,0.01423],["UCEC","Uterine Corpus Endometrial Carcinoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.36,0.0],["UCEC","Uterine Corpus Endometrial Carcinoma","3.30.70.330",43708,"RNA-binding protein 46 (Cancer\\/testis antigen 68) (CT68) (RNA-binding motif protein 46)",2.311,0.02127],["UCEC","Uterine Corpus Endometrial Carcinoma","2.160.10.10",81602,"Zinc finger protein 267 (Zinc finger protein HZF2)",2.306,0.0343],["UCEC","Uterine Corpus Endometrial Carcinoma","2.160.10.10",81840,"Zinc finger protein 333 (Zinc finger protein 333, isoform CRA_a) (cDNA FLJ36709 fis, clone UTERU2009951, highly similar to Zinc finger protein 333)",2.243,0.0409],["UCEC","Uterine Corpus Endometrial Carcinoma","3.10.20.90",16033,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine\\/threonine protein kinase PIK3CA) (EC 2.7.11.1)",2.22,0.0],["UCEC","Uterine Corpus Endometrial Carcinoma","1.10.30.10",4396,"Sex-determining region Y protein (Testis-determining factor)",2.171,0.04338],["UCEC","Uterine Corpus Endometrial Carcinoma","3.40.50.980",69518,"Acyl-CoA synthetase long-chain family member 4, isoform CRA_b (cDNA FLJ78368, highly similar to Homo sapiens acyl-CoA synthetase long-chain family member 4 (ACSL4), transcript variant 1, mRNA)",2.14,0.00481],["UCEC","Uterine Corpus Endometrial Carcinoma","2.30.29.30",22238,"RAC-alpha serine\\/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene)",2.128,0.04441],["UCEC","Uterine Corpus Endometrial Carcinoma","1.10.10.60",124590,"POU class 1 homeobox 1 (Pituitary-specific positive transcription factor 1)",2.061,0.00481],["UCEC","Uterine Corpus Endometrial Carcinoma","2.60.40.150",15035,"Synaptotagmin-C (Synaptic vesicle protein O-p65-C)",2.027,0.01704],["UCEC","Uterine Corpus Endometrial Carcinoma","3.40.50.410",19365,"Vitrin",1.988,0.03408],["UCEC","Uterine Corpus Endometrial Carcinoma","3.30.810.10",1088,"Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha) (Phosphatidylinositol 4-phosphate 5-kinase type I beta) (PI4P5KIbeta)",1.906,0.04441],["UCEC","Uterine Corpus Endometrial Carcinoma","1.10.10.10",264994,"Forkhead box protein G1 (Brain factor 1) (BF-1) (BF1) (Brain factor 2) (BF-2) (BF2) (hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1) (HFK1) (Forkhead-related protein FKHL2) (HFK2) (Forkhead-related protein FKHL3) (HFK3)",1.88,0.00315],["UCEC","Uterine Corpus Endometrial Carcinoma","2.130.10.10",102894,"F-box\\/WD repeat-containing protein sel-10 (Egg laying defective protein 41) (Suppressor\\/enhancer of lin-12 protein 10)",1.83,0.0],["UCEC","Uterine Corpus Endometrial Carcinoma","3.20.20.70",120783,"4-hydroxy-2-oxovalerate aldolase (HOA) (EC 4.1.3.39) (4-hydroxy-2-keto-pentanoic acid aldolase) (4-hydroxy-2-oxohexanoate aldolase) (EC 4.1.3.n1) (4-hydroxy-2-oxopentanoate aldolase)",1.799,0.00481],["UCEC","Uterine Corpus Endometrial Carcinoma","1.20.1270.60",4578,"Brain cDNA, clone: QccE-15936, similar to human ADP-ribosylation factor interacting protein 2 (arfaptin2) (ARFIP2),",1.785,0.02517],["UCEC","Uterine Corpus Endometrial Carcinoma","2.170.240.10",110,"Collagen alpha-2(IV) chain (Lethal protein 2)",1.693,0.0303],["UCEC","Uterine Corpus Endometrial Carcinoma","2.60.40.1330",9702,"Contactin-3 (Brain-derived immunoglobulin superfamily protein 1) (BIG-1) (Plasmacytoma-associated neuronal glycoprotein)",1.684,0.04544],["UCEC","Uterine Corpus Endometrial Carcinoma","1.25.40.70",2223,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine\\/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)",1.59,0.0],["UCEC","Uterine Corpus Endometrial Carcinoma","2.60.40.10",137565,"Sialic acid-binding Ig-like lectin 12 (Siglec-12) (Myeloid inhibitory siglec) (MIS) (Sialic acid-binding Ig-like lectin 5) (Siglec-5) (Sialic acid-binding Ig-like lectin E) (Siglec-E) (mSiglec-E) (Sialic acid-binding Ig-like lectin-like 1) (Siglec-L1)",1.522,0.03408],["UCEC","Uterine Corpus Endometrial Carcinoma","1.10.1070.11",1687,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine\\/threonine protein kinase PIK3CA) (EC 2.7.11.1)",1.451,0.01023],["UCEC","Uterine Corpus Endometrial Carcinoma","1.10.238.10",32830,"Calcium binding protein 2, isoform CRA_b (Calcium-binding protein 2)",1.399,0.03214],["UCEC","Uterine Corpus Endometrial Carcinoma","3.40.50.300",630744,"Ras protein let-60 (Abnormal cell lineage protein 34) (Lethal protein 60)",1.11,0.01423],["UCS","Uterine Carcinosarcoma","2.130.10.10",102894,"F-box\\/WD repeat-containing protein sel-10 (Egg laying defective protein 41) (Suppressor\\/enhancer of lin-12 protein 10)",2.508,0.0001],["UCS","Uterine Carcinosarcoma","2.60.40.720",232,"Cellular tumor antigen p53 (Tumor suppressor p53)",2.473,0.0]]}